Request for information export this page to PDF

A long tradition of Success

Haselmeier History 1920 - glas syringe janet

1920

Wilhelm Haselmeier GmbH & Co is founded in Stuttgart-Degerloch, Germany.

The company specialized in the development and supply of glass syringes, special syringes, stethoscopes and products for diagnostics.

1963

Haselmeier developed and produced a semi-automated autoinjector for glass insulin syringes. Haselmeier is the first company to introduce an autoinjector.

1978

Haselmeier enters the Diabetes market with the development and supply of Diamatic, a fully automatic autoinjector for disposable insulin syringes.

The production is moved to a new factory in Buchen im Odenwald, Germany.

1993

Haselmeier expands its pen franchise with the development and supply of a fully automatic insulin pen with hidden needle.

1998

Haselmeier develops the Penlet, a fixed dose, multiple injections disposable autoinjector for low molecular weight heparin.

Haselmeier History 2001 - Key of Success

2001

Haselmeier develops and supplies a fully automatic pen injector with hidden needle for growth hormone. The one.click - based on this platform - is exclusively launched by Serono, today Merck Serono.

2002

Haselmeier establishes a manufacturing site in Dnesice, Czech Republic for metal turning and for pen assembly.

2003

Haselmeier develops and supplies a new pen injector for insulin therapy that incorporates 3ml cartridges. The DIAPEN® - based on this platform - is launched in Germany.

2004

Haselmeier establishes an office in Severna Park MD, Unites States.

2005

The BerliPen® areo 1 is launched by Berlin-Chemie in Germany, as a reusable pen for insulin therapy. This pen offers state-of-the-art design and function.

2008

Haselmeier establishes its International Business Office in Zurich, Switzerland.

The BerliPen® areo 2 is launched in Germany and offers significant function and design improvements over the previous version.

Haselmeier 2009 - Hands holding a little tree

2009

Haselmeier opens a representation office in Gurgaon, India and expands its manufacturing site in the Czech Republic.

The TactiPen® is launched by Sanofi-Aventis in Germany as a reusable pen for insulin therapy. In Japan the same pen is marketed under the name iTango®.

2010

Haselmeier opens a new manufacturing site in the Czech Republic and expends his logistic and storage area in its German site in Buchen.

Haselmeier Today - Innovation

Haselmeier today

Haselmeier has locations on 3 continents in 5 countries and provides products to pharmaceutical companies worldwide.

 

Haselmeier is offering experience, competence and expertise in:

  • The development/production of pen injectors and auto injectors for self-administration of medicines through subcutaneous injection
  • Custom design and production of medical devices
  • Product design in simultaneous engineering to optimize the development and production processes
  • Quality Management System to guarantee a cost effective, consistent and high quality product